Shares of Glenmark Pharmaceuticals rose nearly 3 per cent after the company said one of its deals with Sanofi signed in May,had got US clearance and it has received $25 million upfront payment from the French healthcare giant. At 9.34 a.m.,shares of the company were up 2.15 per cent at Rs 318.60.
You have exhausted your monthly limit of free stories.
Read more stories for free with an Express account.
